Rocket Lab Corp 8-K

What Happened
Rocket Lab Corporation (RKLB) filed an 8-K on May 8, 2026 disclosing a prospectus supplement to its Form S-3ASR registration statement that registers the resale of up to 2,277,002 shares of common stock. Those shares were issued on April 14, 2026 in a private placement tied to Rocket Lab’s previously announced acquisition of Mynaric AG under a Stock Purchase Agreement dated September 25, 2025 (with joinders dated April 13, 2026). The prospectus supplement was filed pursuant to that Stock Purchase Agreement.

Key Details

• 2,277,002 shares of common stock are covered by the prospectus supplement.
• Shares were issued in a private placement on April 14, 2026 in connection with the Mynaric AG acquisition.
• The underlying Stock Purchase Agreement is dated September 25, 2025 (joinders April 13, 2026).
• A legal opinion from Goodwin Procter LLP (Exhibit 5.1) and its consent (Exhibit 23.1) are filed and incorporated by reference into the registration statement.

Why It Matters
This filing registers the resale of previously issued shares, enabling the selling stockholders to resell those 2,277,002 shares under Rocket Lab’s existing S-3ASR registration statement. For investors, the action is administrative and related to post-acquisition paperwork rather than a new capital raise; it clarifies the resale mechanics and includes the company’s legal opinion supporting the registration.